Health Technology Assessment

MEDLIOR offers high-quality and cost-effective support for health technology assessment (HTA) submissions in Canada and the UK.

For Canadian submissions, MEDLIOR’s expertise includes development of the economic and clinical components required for public and private plans, as well as preparation and distribution of the submission packages to payers across Canada.

Our team is experienced with preparing submissions for the Canadian Agency for Drugs and Technologies in Canada (CADTH) Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR), with services that include:

  • Development of the Clinical Summary and supporting documentation
  • Adaptation or preparation of the Cost-Effectiveness Analysis
  • Response to the CADTH Reviewers Report
  • Adapting CDR reports for submission to INESSS (Quebec)

For our UK clients, MEDLIOR works with our Strategic Partners to prepare submissions for the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC), with services that include:

  • Systematic review and network meta-analysis
  • Development of an economic model
  • Company Evidence Submission (NICE)
  • New Product Assessment Form (SMC)
  • Post-submission support

Our client-focused project management ensures that the quality and rigor of the submission package is tailored to the needs of your submission.